SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000921895-22-003082
Filing Date
2022-11-17
Accepted
2022-11-18 11:02:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 dfan14a13616dffn_11172022.htm DFAN14A 40006
  Complete submission text file 0000921895-22-003082.txt   41571
Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Subject) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-37942 | Film No.: 221401044
SIC: 2834 Pharmaceutical Preparations

Mailing Address 250 W. 55TH ST., #3401 NEW YORK NY 10019
Business Address
Dobkin David (Filed by) CIK: 0001806055 (see all company filings)

Type: DFAN14A